Does early sulfasalazine treatment provide long-term benefits to patients with juvenile idiopathic arthritis?

被引：0

作者：

Tracy V Ting

Daniel J Lovell

机构：

[1] OH,TV Ting is a 2nd year Pediatric Rheumatology Fellow and DJ Lovell holds the Joseph E Levinson Chair in Pediatric Rheumatology and is the Associate Director of the Division of Rheumatology at Cincinnati Children's Hospital Medical Center in Cincinnati

[2] USA.,undefined

来源：

Nature Clinical Practice Rheumatology | 2008年 / 4卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The small, well-designed, observational study by van Rossum et al. raises and addresses questions of great significance for the treatment of children with JIA. The original RCT demonstrated significant benefits of sulfasalazine over placebo that, by today's standards, would be considered only moderate clinical improvement. Despite these initial modest effects, the sulfasalazine group demonstrated improved outcomes compared with the placebo group 9 years later.

引用

页码：344 / 345

页数：1

共 50 条

[21] Etanercept in treatment of juvenile idiopathic arthritis (JIA): Results of long-term study
Calvo, I
Ceballos, E
Soriano, J
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 495 - 495
[22] Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis
Lovell, Daniel J.
Giannini, Edward H.
Reiff, Andreas O.
Kimura, Yukiko
Li, Suzanne
Hashkes, Philip J.
Wallace, Carol A.
Onel, Karen B.
Foell, Dirk
Wu, Richard
Biedermann, Stephanie
Hamilton, Jennifer D.
Radin, Allen R.
ARTHRITIS AND RHEUMATISM, 2013, 65 (09): : 2486 - 2496
[23] Long-term Safety Profile of Anakinra in Patients with Systemic Juvenile Idiopathic Arthritis
Giancane, Gabriella
Papa, Riccardo
Vastert, Sebastiaan
Bagnasco, Francesca
Swart, Joost
Quartier, Pierre
Anton, Jordi
Paut, Isabelle Kone
Kamphuis, Sylvia
Herlin, Troels
Sanner, Helga
De Benedetti, Fabrizio
Tsitsami, Elena
Nielsen, Susan Mary
Moreno, Estefania
Pallotti, Chiara
Franck-Larsson, Karin
Malmstrom, Hakan
Cederholm, Susanna
Raat, Nico Wulff
Ruperto, Nicolino
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[24] SULFASALAZINE FOR RHEUMATOID-ARTHRITIS - LONG-TERM RESULTS OF TREATMENT
AMOS, RS
BAX, DE
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1986, : 66 - 66
[25] LONG-TERM OUTCOME OF TREATMENT WITH SULFASALAZINE IN RHEUMATOID-ARTHRITIS
SITUNAYAKE, RD
MCCONKEY, B
DRUGS, 1986, 32 : 71 - 72
[26] Long-Term Safety of Adalimumab Treatment in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis and Enthesitis-Related Arthritis
Lovell, Daniel
Ruperto, Nicolino
Kingsbury, Daniel J.
Burgos-Vargas, Ruben
Imagawa, Tomoyuki
Horneff, G.
Quartier, Pierre
Goodman, Steven
Reiff, Andreas
Giannini, Edward H.
Cardoso, Anabela
Anderson, Jaclyn K.
Varothai, Nupun A.
Kalabic, Jasmina
Martini, Alberto
ARTHRITIS & RHEUMATOLOGY, 2015, 67
[27] LONG-TERM SAFETY OF ADALIMUMAB TREATMENT IN PEDIATRIC PATIENTS WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS AND ENTHESITIS-RELATED ARTHRITIS
Ruperto, N.
Lovell, D. J.
Kingsbury, D. J.
Burgos-Vargas, R.
Imagawa, T.
Horneff, G.
Quartier, P.
Goodman, S. I.
Reiff, A.
Giannini, E. H.
Cardoso, A.
Anderson, J. K.
Varothai, N. A.
Kalabic, J.
Martini, A.
ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 610 - 611
[28] Does mandatory CSR provide long-term benefits to shareholders?
Juniarti
SOCIAL RESPONSIBILITY JOURNAL, 2021, 17 (06) : 776 - 794
[29] A lifelong journey: Long-term perspectives on Juvenile Idiopathic Arthritis
Ramos, Filipa Oliveira
Zinterl, Carolina
Fonseca, Joao Eurico
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2024, 38 (03):
[30] Early treatment with infliximabin patients with juvenile idiopathic arthritis
TV Sleptsova
EI Alexeeva
SI Valieva
TM Bzarova
KB Isayeva
RV Denisova
EV Mitenko
Pediatric Rheumatology, 9 (Suppl 1)

← 1 2 3 4 5 →